Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 64 entries
Sorted by: Best Match Show Resources per page
Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression.

Molecular and cellular endocrinology

Chattopadhyay S, Joharapurkar A, Das N, Khatoon S, Kushwaha S, Gurjar AA, Singh AK, Shree S, Ahmed MZ, China SP, Pal S, Kumar H, Ramachandran R, Patel V, Trivedi AK, Lahiri A, Jain MR, Chattopadhyay N, Sanyal S.
PMID: 34856343
Mol Cell Endocrinol. 2022 Jan 15;540:111525. doi: 10.1016/j.mce.2021.111525. Epub 2021 Nov 29.

Adiponectin and insulin resistance creates a vicious cycle that exacerbates type 2 diabetes. Earlier, we observed that female leptin receptor-deficient BLKS mice (BKS-db/db) were more sensitive to an adiponectin mimetic GTDF than males, which led us to explore if...

Cite
Chattopadhyay S, Joharapurkar A, Das N, et al. Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression. Mol Cell Endocrinol. 2021;540:111525doi: 10.1016/j.mce.2021.111525.
Chattopadhyay, S., Joharapurkar, A., Das, N., Khatoon, S., Kushwaha, S., Gurjar, A. A., Singh, A. K., Shree, S., Ahmed, M. Z., China, S. P., Pal, S., Kumar, H., Ramachandran, R., Patel, V., Trivedi, A. K., Lahiri, A., Jain, M. R., Chattopadhyay, N., & Sanyal, S. (2022). Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression. Molecular and cellular endocrinology, 540111525. https://doi.org/10.1016/j.mce.2021.111525
Chattopadhyay, Sourav, et al. "Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression." Molecular and cellular endocrinology vol. 540 (2022): 111525. doi: https://doi.org/10.1016/j.mce.2021.111525
Chattopadhyay S, Joharapurkar A, Das N, Khatoon S, Kushwaha S, Gurjar AA, Singh AK, Shree S, Ahmed MZ, China SP, Pal S, Kumar H, Ramachandran R, Patel V, Trivedi AK, Lahiri A, Jain MR, Chattopadhyay N, Sanyal S. Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression. Mol Cell Endocrinol. 2022 Jan 15;540:111525. doi: 10.1016/j.mce.2021.111525. Epub 2021 Nov 29. PMID: 34856343.
Copy Download .nbib Format: NLM
Estrogen Receptor 1 Gene rs22346939 and rs9340799 Variants are Associated with Major Depressive Disorder and its Clinical Features.

Current neurovascular research

Ozsoy F, Nursal AF, Karakus N, Demir MO, Yigit S.
PMID: 34060989
Curr Neurovasc Res. 2021;18(1):12-19. doi: 10.2174/1567202618666210531122239.

OBJECTIVE: Major Depressive Disorder (MDD) is a major health problem worldwide. Estrogen interacts with the central nervous system and has been shown to affect anxiety and depressive behavior. Estrogen mediates its effects by connecting its receptors, estrogen receptors 1...

Cite
Ozsoy F, Nursal AF, Karakus N, et al. Estrogen Receptor 1 Gene rs22346939 and rs9340799 Variants are Associated with Major Depressive Disorder and its Clinical Features. Curr Neurovasc Res. 2021;18(1):12-19doi: 10.2174/1567202618666210531122239.
Ozsoy, F., Nursal, A. F., Karakus, N., Demir, M. O., & Yigit, S. (2021). Estrogen Receptor 1 Gene rs22346939 and rs9340799 Variants are Associated with Major Depressive Disorder and its Clinical Features. Current neurovascular research, 18(1), 12-19. https://doi.org/10.2174/1567202618666210531122239
Ozsoy, Filiz, et al. "Estrogen Receptor 1 Gene rs22346939 and rs9340799 Variants are Associated with Major Depressive Disorder and its Clinical Features." Current neurovascular research vol. 18,1 (2021): 12-19. doi: https://doi.org/10.2174/1567202618666210531122239
Ozsoy F, Nursal AF, Karakus N, Demir MO, Yigit S. Estrogen Receptor 1 Gene rs22346939 and rs9340799 Variants are Associated with Major Depressive Disorder and its Clinical Features. Curr Neurovasc Res. 2021;18(1):12-19. doi: 10.2174/1567202618666210531122239. PMID: 34060989.
Copy Download .nbib Format: NLM
Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression.

Molecular and cellular endocrinology

Chattopadhyay S, Joharapurkar A, Das N, Khatoon S, Kushwaha S, Gurjar AA, Singh AK, Shree S, Ahmed MZ, China SP, Pal S, Kumar H, Ramachandran R, Patel V, Trivedi AK, Lahiri A, Jain MR, Chattopadhyay N, Sanyal S.
PMID: 34856343
Mol Cell Endocrinol. 2021 Nov 29;540:111525. doi: 10.1016/j.mce.2021.111525. Epub 2021 Nov 29.

Adiponectin and insulin resistance creates a vicious cycle that exacerbates type 2 diabetes. Earlier, we observed that female leptin receptor-deficient BLKS mice (BKS-db/db) were more sensitive to an adiponectin mimetic GTDF than males, which led us to explore if...

Cite
Chattopadhyay S, Joharapurkar A, Das N, et al. Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression. Mol Cell Endocrinol. 2021;540:111525doi: 10.1016/j.mce.2021.111525.
Chattopadhyay, S., Joharapurkar, A., Das, N., Khatoon, S., Kushwaha, S., Gurjar, A. A., Singh, A. K., Shree, S., Ahmed, M. Z., China, S. P., Pal, S., Kumar, H., Ramachandran, R., Patel, V., Trivedi, A. K., Lahiri, A., Jain, M. R., Chattopadhyay, N., & Sanyal, S. (2021). Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression. Molecular and cellular endocrinology, 540111525. https://doi.org/10.1016/j.mce.2021.111525
Chattopadhyay, Sourav, et al. "Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression." Molecular and cellular endocrinology vol. 540 (2021): 111525. doi: https://doi.org/10.1016/j.mce.2021.111525
Chattopadhyay S, Joharapurkar A, Das N, Khatoon S, Kushwaha S, Gurjar AA, Singh AK, Shree S, Ahmed MZ, China SP, Pal S, Kumar H, Ramachandran R, Patel V, Trivedi AK, Lahiri A, Jain MR, Chattopadhyay N, Sanyal S. Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression. Mol Cell Endocrinol. 2021 Nov 29;540:111525. doi: 10.1016/j.mce.2021.111525. Epub 2021 Nov 29. PMID: 34856343.
Copy Download .nbib Format: NLM
Endoplasmic reticulum stress and oncomir-associated chemotherapeutic drug resistance mechanisms in breast cancer tumors.

Turkish journal of biology = Turk biyoloji dergisi

Mehdizadehtapeh L, Obakan Yerlİkaya P.
PMID: 33597817
Turk J Biol. 2021 Feb 09;45(1):1-16. doi: 10.3906/biy-2010-62. eCollection 2021.

Breast cancer, as a heterogenous malign disease among the top five leading causes of cancer death worldwide, is defined as by far the most common malignancy in women. It contributes to 25% of all cancer-associated deaths after menopause. Breast...

Cite
Mehdizadehtapeh L, Obakan Yerlİkaya P. Endoplasmic reticulum stress and oncomir-associated chemotherapeutic drug resistance mechanisms in breast cancer tumors. Turk J Biol. 2021;45(1):1-16doi: 10.3906/biy-2010-62.
Mehdizadehtapeh, L., & Obakan Yerlİkaya, P. (2021). Endoplasmic reticulum stress and oncomir-associated chemotherapeutic drug resistance mechanisms in breast cancer tumors. Turkish journal of biology = Turk biyoloji dergisi, 45(1), 1-16. https://doi.org/10.3906/biy-2010-62
Mehdizadehtapeh, Leila, and Obakan Yerlİkaya, Pınar. "Endoplasmic reticulum stress and oncomir-associated chemotherapeutic drug resistance mechanisms in breast cancer tumors." Turkish journal of biology = Turk biyoloji dergisi vol. 45,1 (2021): 1-16. doi: https://doi.org/10.3906/biy-2010-62
Mehdizadehtapeh L, Obakan Yerlİkaya P. Endoplasmic reticulum stress and oncomir-associated chemotherapeutic drug resistance mechanisms in breast cancer tumors. Turk J Biol. 2021 Feb 09;45(1):1-16. doi: 10.3906/biy-2010-62. eCollection 2021. PMID: 33597817; PMCID: PMC7877716.
Copy Download .nbib Format: NLM
Cardiovascular roles of estrogen receptors: insights gained from knockout models.

Nuclear receptor signaling

Otsuki M, Dahlman-Wright K, Gustafsson JA.
PMID: 16604173
Nucl Recept Signal. 2003;1:e003. doi: 10.1621/nrs.01003. Epub 2003 Jun 15.

The effects of estrogen are mediated through two functionally distinct receptors, estrogen receptor alpha (ER- alpha ), and estrogen receptor beta (ER- beta ), both of which are expressed in the cardiovascular system. The etiology of cardiovascular disease is...

Cite
Otsuki M, Dahlman-Wright K, Gustafsson JA. Cardiovascular roles of estrogen receptors: insights gained from knockout models. Nucl Recept Signal. 2003;1:e003doi: 10.1621/nrs.01003.
Otsuki, M., Dahlman-Wright, K., & Gustafsson, J. A. (2003). Cardiovascular roles of estrogen receptors: insights gained from knockout models. Nuclear receptor signaling, 1e003. https://doi.org/10.1621/nrs.01003
Otsuki, Michio, et al. "Cardiovascular roles of estrogen receptors: insights gained from knockout models." Nuclear receptor signaling vol. 1 (2003): e003. doi: https://doi.org/10.1621/nrs.01003
Otsuki M, Dahlman-Wright K, Gustafsson JA. Cardiovascular roles of estrogen receptors: insights gained from knockout models. Nucl Recept Signal. 2003;1:e003. doi: 10.1621/nrs.01003. Epub 2003 Jun 15. PMID: 16604173; PMCID: PMC1402221.
Copy Download .nbib Format: NLM
Responding to the challenges of breast cancer in egypt and other arab countries.

Journal of the Egyptian National Cancer Institute

El Saghir NS.
PMID: 20571588
J Egypt Natl Canc Inst. 2008 Dec;20(4):309-12.

Physicians in Egypt and other Arab and developing countries still have to deal on a daily basis with large numbers of patients with advanced stages of breast cancer at presentation. Efforts at measuring the magnitude of the breast cancer...

Cite
El Saghir NS. Responding to the challenges of breast cancer in egypt and other arab countries. J Egypt Natl Canc Inst. 2008;20(4):309-12
El Saghir, N. S. (2008). Responding to the challenges of breast cancer in egypt and other arab countries. Journal of the Egyptian National Cancer Institute, 20(4), 309-12.
El Saghir, Nagi S. "Responding to the challenges of breast cancer in egypt and other arab countries." Journal of the Egyptian National Cancer Institute vol. 20,4 (2008): 309-12.
El Saghir NS. Responding to the challenges of breast cancer in egypt and other arab countries. J Egypt Natl Canc Inst. 2008 Dec;20(4):309-12. PMID: 20571588.
Copy Download .nbib Format: NLM
Pathologists' Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer.

Breast care (Basel, Switzerland)

[No authors listed]
PMID: 21049068
Breast Care (Basel). 2010;5(3):185-187. doi: 10.1159/000315039. Epub 2010 Jun 08.

Expression of the hormone receptors (estrogen receptor (ER) and progesterone receptor (PR)) as well as overexpression / amplification of the human epi-dermal growth factor receptor-2 (HER2) have not only been identified as important prognostic factors among patients with breast...

Cite
Pathologists' Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. Breast Care (Basel). 2010;5(3):185-187doi: 10.1159/000315039.
(2010). Pathologists' Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. Breast care (Basel, Switzerland), 5(3), 185-187. https://doi.org/10.1159/000315039
"Pathologists' Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer." Breast care (Basel, Switzerland) vol. 5,3 (2010): 185-187. doi: https://doi.org/10.1159/000315039
Pathologists' Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. Breast Care (Basel). 2010;5(3):185-187. doi: 10.1159/000315039. Epub 2010 Jun 08. PMID: 21049068; PMCID: PMC2931060.
Copy Download .nbib Format: NLM
Association of mammographic density with pathologic findings.

Iranian Red Crescent medical journal

Ahmadinejad N, Movahedinia S, Movahedinia S, Shahriari M.
PMID: 24693404
Iran Red Crescent Med J. 2013 Dec;15(12):e16698. doi: 10.5812/ircmj.16698. Epub 2013 Dec 05.

BACKGROUND: Breast cancer is one of the most common cancers in the world and is the first cause of death due to cancer among women. Mammography is the best screening method and mammographic density, which determines the percentage of...

Cite
Ahmadinejad N, Movahedinia S, Movahedinia S, et al. Association of mammographic density with pathologic findings. Iran Red Crescent Med J. 2013;15(12):e16698doi: 10.5812/ircmj.16698.
Ahmadinejad, N., Movahedinia, S., Movahedinia, S., & Shahriari, M. (2013). Association of mammographic density with pathologic findings. Iranian Red Crescent medical journal, 15(12), e16698. https://doi.org/10.5812/ircmj.16698
Ahmadinejad, Nasrin, et al. "Association of mammographic density with pathologic findings." Iranian Red Crescent medical journal vol. 15,12 (2013): e16698. doi: https://doi.org/10.5812/ircmj.16698
Ahmadinejad N, Movahedinia S, Movahedinia S, Shahriari M. Association of mammographic density with pathologic findings. Iran Red Crescent Med J. 2013 Dec;15(12):e16698. doi: 10.5812/ircmj.16698. Epub 2013 Dec 05. PMID: 24693404; PMCID: PMC3955519.
Copy Download .nbib Format: NLM
Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ.

Journal of breast cancer

Min Y, Bae SY, Lee HC, Lee JH, Kim M, Kim J, Lee SK, Kil WH, Kim SW, Lee JE, Nam SJ.
PMID: 24454462
J Breast Cancer. 2013 Dec;16(4):404-9. doi: 10.4048/jbc.2013.16.4.404. Epub 2013 Dec 31.

PURPOSE: Tubular carcinoma (TC) of the breast is an uncommon histological subtype of invasive breast cancer with an excellent prognosis compared with standard invasive ductal carcinoma. Recent studies suggested a possible precursor role for low grade ductal carcinoma in...

Cite
Min Y, Bae SY, Lee HC, et al. Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ. J Breast Cancer. 2013;16(4):404-9doi: 10.4048/jbc.2013.16.4.404.
Min, Y., Bae, S. Y., Lee, H. C., Lee, J. H., Kim, M., Kim, J., Lee, S. K., Kil, W. H., Kim, S. W., Lee, J. E., & Nam, S. J. (2013). Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ. Journal of breast cancer, 16(4), 404-9. https://doi.org/10.4048/jbc.2013.16.4.404
Min, Yejin, et al. "Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ." Journal of breast cancer vol. 16,4 (2013): 404-9. doi: https://doi.org/10.4048/jbc.2013.16.4.404
Min Y, Bae SY, Lee HC, Lee JH, Kim M, Kim J, Lee SK, Kil WH, Kim SW, Lee JE, Nam SJ. Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ. J Breast Cancer. 2013 Dec;16(4):404-9. doi: 10.4048/jbc.2013.16.4.404. Epub 2013 Dec 31. PMID: 24454462; PMCID: PMC3893342.
Copy Download .nbib Format: NLM
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer.

Genetics & epigenetics

Inoue K, Fry EA.
PMID: 26692764
Genet Epigenet. 2015 Dec 02;7:19-32. doi: 10.4137/GEG.S35500. eCollection 2015.

Breast cancer (BC) is the most common cause of cancer-related death among women under the age of 50 years. Established biomarkers, such as hormone receptors (estrogen receptor [ER]/progesterone receptor) and human epidermal growth factor receptor 2 (HER2), play significant...

Cite
Inoue K, Fry EA. Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer. Genet Epigenet. 2015;7:19-32doi: 10.4137/GEG.S35500.
Inoue, K., & Fry, E. A. (2015). Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer. Genetics & epigenetics, 719-32. https://doi.org/10.4137/GEG.S35500
Inoue, Kazushi, and Fry, Elizabeth A. "Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer." Genetics & epigenetics vol. 7 (2015): 19-32. doi: https://doi.org/10.4137/GEG.S35500
Inoue K, Fry EA. Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer. Genet Epigenet. 2015 Dec 02;7:19-32. doi: 10.4137/GEG.S35500. eCollection 2015. PMID: 26692764; PMCID: PMC4669075.
Copy Download .nbib Format: NLM
Receptors and signaling pathways involved in proliferation and differentiation of Sertoli cells.

Spermatogenesis

Lucas TF, Nascimento AR, Pisolato R, Pimenta MT, Lazari MF, Porto CS.
PMID: 25225624
Spermatogenesis. 2014 Feb 20;4:e28138. doi: 10.4161/spmg.28138. eCollection 2014.

The identification of the hormones and other factors regulating Sertoli cell survival, proliferation, and maturation in neonatal, peripubertal, and pubertal life remains one of the most critical questions in testicular biology. The regulation of Sertoli cell proliferation and differentiation...

Cite
Lucas TF, Nascimento AR, Pisolato R, et al. Receptors and signaling pathways involved in proliferation and differentiation of Sertoli cells. Spermatogenesis. 2014;4:e28138doi: 10.4161/spmg.28138.
Lucas, T. F., Nascimento, A. R., Pisolato, R., Pimenta, M. T., Lazari, M. F., & Porto, C. S. (2014). Receptors and signaling pathways involved in proliferation and differentiation of Sertoli cells. Spermatogenesis, 4e28138. https://doi.org/10.4161/spmg.28138
Lucas, Thaís Fg, et al. "Receptors and signaling pathways involved in proliferation and differentiation of Sertoli cells." Spermatogenesis vol. 4 (2014): e28138. doi: https://doi.org/10.4161/spmg.28138
Lucas TF, Nascimento AR, Pisolato R, Pimenta MT, Lazari MF, Porto CS. Receptors and signaling pathways involved in proliferation and differentiation of Sertoli cells. Spermatogenesis. 2014 Feb 20;4:e28138. doi: 10.4161/spmg.28138. eCollection 2014. PMID: 25225624; PMCID: PMC4160334.
Copy Download .nbib Format: NLM
Effects of 17β-estradiol and estrogen receptor antagonists on the proliferation of gastric cancer cell lines.

Journal of gastric cancer

Kim MJ, Cho SI, Lee KO, Han HJ, Song TJ, Park SH.
PMID: 24156037
J Gastric Cancer. 2013 Sep;13(3):172-8. doi: 10.5230/jgc.2013.13.3.172. Epub 2013 Sep 30.

PURPOSE: THE AIMS OF THIS STUDY WERE AS FOLLOW: 1) to de scribe the expression status of estrogen receptor-α and -β mRNAs in five gastric carcinoma cell lines; 2) to evaluate in vitro the effects of 17β-estradiol and estrogen...

Cite
Kim MJ, Cho SI, Lee KO, et al. Effects of 17β-estradiol and estrogen receptor antagonists on the proliferation of gastric cancer cell lines. J Gastric Cancer. 2013;13(3):172-8doi: 10.5230/jgc.2013.13.3.172.
Kim, M. J., Cho, S. I., Lee, K. O., Han, H. J., Song, T. J., & Park, S. H. (2013). Effects of 17β-estradiol and estrogen receptor antagonists on the proliferation of gastric cancer cell lines. Journal of gastric cancer, 13(3), 172-8. https://doi.org/10.5230/jgc.2013.13.3.172
Kim, Myung-Jin, et al. "Effects of 17β-estradiol and estrogen receptor antagonists on the proliferation of gastric cancer cell lines." Journal of gastric cancer vol. 13,3 (2013): 172-8. doi: https://doi.org/10.5230/jgc.2013.13.3.172
Kim MJ, Cho SI, Lee KO, Han HJ, Song TJ, Park SH. Effects of 17β-estradiol and estrogen receptor antagonists on the proliferation of gastric cancer cell lines. J Gastric Cancer. 2013 Sep;13(3):172-8. doi: 10.5230/jgc.2013.13.3.172. Epub 2013 Sep 30. PMID: 24156037; PMCID: PMC3804676.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 64 entries